LLBO OTC
Lifeline Biotechnologies, Inc.
1W: +0.0%
1M: -20.0%
3M: -42.9%
YTD: -42.9%
1Y: -60.0%
3Y: +100.0%
5Y: -83.3%
$0.00
+0.00 (+33.33%)
Weekly Expected Move ±90.0%
$-0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$140K
+0.0% ▲
3Y CAGR: +40.7%
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
$140K
+0.0% ▲
3Y CAGR: +40.7%
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$70
+0.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2015 | FY2016 | FY2017 | FY2018 |
|---|---|---|---|---|
| — Operating Activities — | ||||
| Net Income | $3K | $6K | $242K | -$43K |
| Depreciation & Amort. | $3K | $3K | $630 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in Working Capital | $45K | -$109K | -$197K | $183K |
| Other Non-Cash Items | -$40K | $114K | $198K | -$183K |
| Operating Cash Flow | $50K | -$101K | $45K | $140K |
| — Investing Activities — | ||||
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | -$83K |
| Investment Sales | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | -$83K |
| — Financing Activities — | ||||
| Net Debt Issuance | -$95K | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $105K | -$50K | -$56K |
| Financing Cash Flow | -$50K | $105K | -$50K | -$56K |
| Net Change in Cash | $470 | $4K | -$4K | $70 |
| Cash End of Period | $753 | $5K | $345 | $415 |
| Free Cash Flow | $50K | -$101K | $45K | $140K |